Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial

Lin, L; Xu, XJ; Yu, YJ; Ye, HJ; He, XQ; Chen, SP; Chen, AQ; Shao, ZL; Chen, P

Chen, P (通讯作者)，Fujian Med Univ, Hosp 900, Joint Logist Team, Fuzong Clin Med Coll, Fuzhou, Fujian, Peoples R China.

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022; 33 (3): 1428

Abstract

Objective There were some clinical studies on GLP-1R agonist liraglutide therapy for psoriasis patients with type 2 diabetes, but there is a lack of r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索